Oncology Clinical Trials in Stanford, CA
As of September 2026, 60 paid clinical trials are recruiting for Oncology in Stanford, California. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Stanford
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
61 clinical trials for Oncology
·Clear filters·Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies
A Study of LY4175408 in Participants With Advanced Cancer
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Study With [225Ac]Ac-FL-020 in mCRPC Participants
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Measuring Surgical Recovery After Radical Cystectomy
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
Childhood Cancer Survivor Study
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Magnetic Resonance Imaging of Breast Cancer
Evaluation of Grief Therapy Approaches for Bereaved Parents
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Top Research Study Locations in Stanford
Researchers run research studies in Stanford, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Stanford University | Autism Spectrum Disorder, Autism, Atrial Fibrillation | 185 |
| Stanford University School of Medicine | Autism Spectrum Disorder, Amyotrophic Lateral Sclerosis, Autism | 44 |
| Stanford University Medical Center | Aortic Valve Stenosis, Atrial Fibrillation, Breast Neoplasms | 35 |
| Stanford Cancer Institute | Locally Advanced Solid Tumor, Metastatic Solid Tumor, Solid Tumor, Adult | 12 |
| Stanford Health Care | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Stroke | 9 |
| Stanford Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 9 |
| Stanford Hospital and Clinics | Abdominal Aortic Aneurysm, Augmented Reality, Blood Loss, Surgical | 8 |
| Stanford Hospital | Aorta; Lesion, Aortic Aneurysm, Thoracic, Aortic Dissection | 6 |
| Stanford Cancer Center | Brain Tumor, Mantle Cell Lymphoma, Melanoma, Cutaneous Malignant | 5 |
| Lucile Packard Children's Hospital | Anesthesia, Congenital Diaphragmatic Hernia, Deletion and Duplication of Mitochondrial DNA | 4 |
| Stanford | Cutaneous Melanoma, Endometriosis, Follicular Lymphoma | 4 |
| Stanford Hospital & Clinics | Aortic Stenosis, Colorectal Cancer, Coronary Artery Disease | 4 |
| Stanford School of Medicine | Resilience, Psychological, Adolescent Congenital Heart Disease, Advance Directives | 4 |
| Clinical Trial Site | Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, Cholesterol Ester Storage Disease | 3 |
| Leland Stanford Junior University | Aneurysm Dissecting, Aneurysm Thoracic, Congenital Heart Disease | 3 |
| Lucile Packard Children's Hospital Stanford | Bronchoplasty, Cervical and Thoracic Tracheoplasty, Cholecystectomy | 3 |
| Stanford Healthcare | Huntington Disease, Pulmonary Arterial Hypertension, Wound of Skin | 3 |
| Alkermes Investigational Site | Bipolar I Disorder, Idiopathic Hypersomnia, Narcolepsy Type 1 | 2 |
| Stanford Healthcare, Stanford Hospital | Erectile Dysfunction, Anorgasmia, Delayed Ejaculation | 2 |
| Stanford Medicine Cancer Center | Neoplasm Metastasis, Carcinoma, Non-Small-Cell Lung, Endometrial Neoplasms | 2 |
| Stanford University (Data Collection Only) | Advanced Melanoma, Bereavement, Cancer | 2 |
| Stanford University - Stanford Children's Health | Nephropathic Cystinosis, RPS19 Deficient Diamond-Blackfan Anemia | 2 |
| Stanford University Hospital | Breast Cancer, Pain Management, Pain Syndrome | 2 |
| 401 Quarry Road (Remote Study) | Autism, Autism Spectrum Disorder, Restricted Behavior | 1 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
Active & Upcoming Studies in Stanford (2026)
Recruiting trials in Stanford grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (84 active studies)
- Prenatal Transplantation for Fetuses With Fanconi Anemia · Phase 1, Phase 2 · Agnieszka Czechowicz
- Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer Imaging · Stanford University
Cardiovascular (43 active studies)
- Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy · Tina Baykaner
- A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis · Phase 2 · Beijing Inno Medicine Co., Ltd.
Neurology & pain (37 active studies)
- Vagus Nerve Stimulation to Enhance Memory in Aging · Stanford University
- Neuraxial Ultrasound Device Study · Stanford University
Mental health & behavior (20 active studies)
- Study of Psilocybin Under Anesthesia Controlled by EEG · Phase 2 · Stanford University
- Phase II: Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings · Stanford University
Diabetes & metabolic (16 active studies)
Pediatric (5 active studies)
- Prenatal Transplantation for Fetuses With Fanconi Anemia · Phase 1, Phase 2 · Agnieszka Czechowicz
- Clinical Trial Evaluating the Effects of Ganaxolone in Children With Autism · Phase 2 · Stanford University
Vaccines (3 active studies)
- High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
- Impact of the Coronavirus (COVID-19) on Patients With Cancer · Stanford University
Common conditions studied in Stanford
- Autism Spectrum Disorder (17 active studies)
- Autism (12 active studies)
- Atrial Fibrillation (7 active studies)
- Breast Cancer (7 active studies)
- Cancer (7 active studies)
- Heart Failure (6 active studies)
Leading research sponsors in Stanford
- Stanford University
- Eli Lilly and Company
- AstraZeneca
- Memorial Sloan Kettering Cancer Center
- Novartis Pharmaceuticals
Frequently asked questions
How many paid clinical trials are currently recruiting in Stanford?
There are approximately 426 recruiting clinical trials in Stanford, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Stanford pay participants?
Most recruiting trials in Stanford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Stanford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Stanford?
The most common conditions under active study in Stanford include Autism Spectrum Disorder (17), Autism (12), Atrial Fibrillation (7), Breast Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Stanford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Stanford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Stanford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Stanford?
Recruiting research sites in Stanford include Stanford University, Stanford University School of Medicine, Stanford University Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Stanford right now?
The largest active categories in Stanford are Cancer & tumors (84), Cardiovascular (43), Neurology & pain (37). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.